Power considerations for clinical trials using multivariate time-to-event data

被引:0
|
作者
Hughes, MD [1 ]
机构
[1] HARVARD UNIV,SCH PUBL HLTH,DEPT BIOSTAT,BOSTON,MA 02115
关键词
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Many clinical trials involve the collection of data on the times to occurrence of different types of events, such as different fungal infections in AIDS research, or of recurrences of the same type, such as successive fits in epilepsy research. The multivariate proportional hazards model allows for analysis of this data and software for doing this is now widely available. In this paper, the approximate power of a clinical trial that aims to use such data for comparing two treatments is derived. Special attention is given to the bivariate case, both to show that the approximation works well and to illustrate how various design parameters affect the power of a trial. As with any multivariate data in clinical trials, there are many conceptual issues that should be considered during trial design; the paper closes with a discussion of some of these. (C) 1997 by John Wiley & Sons, Ltd. Stat. Med., Vol. 16, 865-882 (1997).
引用
收藏
页码:865 / 882
页数:18
相关论文
共 50 条
  • [1] Comparison of Time-to-Event Data for Clinical Trials
    Nadarajah, Saralees
    [J]. MONTE CARLO METHODS AND APPLICATIONS, 2007, 13 (01): : 21 - 35
  • [2] Projection of power and events in clinical trials with a time-to-event outcome
    Royston, Patrick
    Barthel, Friederike M-S
    [J]. STATA JOURNAL, 2010, 10 (03): : 386 - 394
  • [3] Bayesian design of clinical trials using joint models for longitudinal and time-to-event data
    Xu, Jiawei
    Psioda, Matthew A.
    Ibrahim, Joseph G.
    [J]. BIOSTATISTICS, 2022, 23 (02) : 591 - 608
  • [4] Time-To-Event Data: An Overview and Analysis Considerations
    Le-Rademacher, Jennifer
    Wang, Xiaofei
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (07) : 1067 - 1074
  • [5] Predicting events in clinical trials using two time-to-event outcomes
    Mu, Rongji
    Xu, Jin
    [J]. BIOMETRICAL JOURNAL, 2018, 60 (04) : 815 - 826
  • [6] LEVERAGING REAL-WORLD DATA FOR TIME-TO-EVENT ENDPOINTS IN CLINICAL TRIALS
    Parashar, D.
    Almgren, P.
    Berglund, A.
    Guasconi, A.
    Smith, C.
    Torlinska, B.
    Wang, J.
    Wang, Q.
    [J]. VALUE IN HEALTH, 2022, 25 (01) : S256 - S256
  • [7] Sample size considerations for single-arm clinical trials with time-to-event endpoint using the gamma distribution
    Dai, Junqiang
    He, Jianghua
    Phadnis, Milind A.
    [J]. CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2024, 41
  • [8] Bayesian Design of Clinical Trials Using Joint Cure Rate Models for Longitudinal and Time-to-Event Data
    Jiawei Xu
    Matthew A. Psioda
    Joseph G. Ibrahim
    [J]. Lifetime Data Analysis, 2023, 29 : 213 - 233
  • [9] Bayesian Design of Clinical Trials Using Joint Cure Rate Models for Longitudinal and Time-to-Event Data
    Xu, Jiawei
    Psioda, Matthew A.
    Ibrahim, Joseph G.
    [J]. LIFETIME DATA ANALYSIS, 2023, 29 (01) : 213 - 233
  • [10] A Bayesian approach for event predictions in clinical trials with time-to-event outcomes
    Aubel, Paul
    Antigny, Marine
    Fougeray, Ronan
    Dubois, Frederic
    Saint-Hilary, Gaelle
    [J]. STATISTICS IN MEDICINE, 2021, 40 (28) : 6344 - 6359